Keyword: Momenta Pharmaceuticals
News
08.04.2014
- Teva Pharmaceutical Industries, U.S. subsidiary of the Israeli generics drugmaker, has asked the U.S. Supreme Court to stop a lower court ruling from going into effect while the...
News
01.04.2014
- The U.S. Supreme Court on Mar. 31 agreed to hear an appeal filed by Teva Pharmaceutical Industries in a patent fight over top-selling multiple sclerosis drug Copaxone. The move...
News
04.08.2012
- A divided federal appeals court overturned an order in favor of Momenta Pharmaceuticals that had blocked Watson Pharmaceuticals from selling a generic version of the blood-thinning...
News
24.06.2012
- Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
News
01.10.2011
- Momenta Pharmaceuticals announced that it has filed a request for a temporary restraining order and preliminary injunction to prevent Amphastar Pharmaceuticals, Watson...
